Ovid Therapeutics
OVID
OVID
48 hedge funds and large institutions have $49.8M invested in Ovid Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less capital invested
Capital invested by funds: $77.2M → $49.8M (-$27.4M)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.09M | |
| 2 | +$598K | |
| 3 | +$514K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$470K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$420K |
Top Sellers
| 1 | -$6.64M | |
| 2 | -$2.21M | |
| 3 | -$1.78M | |
| 4 |
CC
Casdin Capital
New York
|
-$1.58M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.07M |